Hospitals & Health Systems Medicaid Reimbursement US Health Care Government Funding Law Changes Rules Regarding Dual Eligibles and the Medicaid DSH Hospital-Specific Limit By Charles Luband and Callan Smith
Anti-Kickback Statute Compliance Fraud & Abuse Medicaid Medicare Pharmaceuticals US Health Care HHS-OIG Issues Special Advisory Bulletin on Manufacturer Direct-to-Consumer Programs for Prescription Drugs By Sean Cenawood, Samantha Groden, Christopher Janney, and Gadi Weinreich
Hospitals & Health Systems Managed Care Medicaid Reimbursement US Health Care The $78 Billion Question: What CMS’s Medicaid Health Care-Related Tax Rule Means for States By Charles Luband, Claire Bornstein, and Sarah Winston
Hospitals & Health Systems Medicaid Medicare Pharmaceuticals US Health Care 340B Rebate Model Pilot Program Heads to Court By Sarah Winston
Hospitals & Health Systems Medicaid Medicare News Flash Pharmaceuticals US Health Care 340B at an Inflection Point: Senate Hearing Continues Spotlight on the Program By Sarah Winston, Joanna Borman, and Callan Smith
Compliance Digital Health Fraud & Abuse Medicaid Medicare HHS-OIG’s New RPM Report: Same Risks, Sharper Focus By Ramy Fayed and Danika Rothwell
Medicaid Medicare US Health Care ICYMI: Ongoing Federal Developments Regarding Medicaid Provider Taxes and State Directed Payments By Claire Bornstein and Charles Luband
Fraud & Abuse Hospitals & Health Systems Medicaid News Flash US Health Care The Senate Parliamentarian’s Nearly $175 Billion Health Care Headache By Callan Smith
Anti-Kickback Statute Fraud & Abuse Hospitals & Health Systems Medicaid Medicare US Health Care Fifth Circuit Weighs in Again on Payment for Marketing vs. Referrals under the AKS By Christopher Janney, Samantha Groden, Margo Smith, and Gadi Weinreich
Anti-Kickback Statute Fraud & Abuse Hospitals & Health Systems Medicaid Medicare US Health Care Another Circuit Court Weighs in on Marketing and Promotion Under the AKS By Christopher Janney, Samantha Groden, and Margo Smith
Medicaid Medicare News Flash Pharmaceuticals US Health Care New Executive Order Focused on Drug Prices Suggests Changes Coming Through Wide-Ranging Measures By Callan Smith
Compliance Digital Health Hospitals & Health Systems Medicaid Medicare Reimbursement US Health Care CMS Issues 2025 Marketplace Integrity and Affordability Proposed Rule By Kate Sullivan Morgan
